| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Bexarotene | FIMM | pan-cancer | AAC | -0.22 | 0.1 |
| mRNA | Doxorubicin | gCSI | pan-cancer | AAC | -0.2 | 9e-05 |
| mRNA | AZD0530 | FIMM | pan-cancer | AAC | -0.2 | 0.2 |
| mRNA | S-Trityl-L-cysteine | FIMM | pan-cancer | AAC | -0.2 | 0.3 |
| mRNA | Sorafenib | FIMM | pan-cancer | AAC | -0.18 | 0.3 |
| mRNA | Gemcitabine | gCSI | pan-cancer | AAC | -0.18 | 0.001 |
| mRNA | AZD6244 | UHNBreast | pan-cancer | AAC | -0.18 | 0.6 |
| mRNA | AS601245 | GDSC1000 | pan-cancer | AAC | -0.16 | 5e-06 |
| mRNA | lapatinib | UHNBreast | pan-cancer | AAC | -0.16 | 0.6 |
| mRNA | serdemetan | FIMM | pan-cancer | AAC | -0.15 | 0.3 |